Thyroid Gland Medullary Carcinoma — Trials

Thyroid Gland Medullary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

105 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 25
Recruiting: 8
Ph III recruiting: 1
Growth YoY: —
Industry share: 32%
Top sponsor: Eli Lilly and Company
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02431715	18F-FDOPA PET in Neuroendocrine Tumours	no longer available	—	—	British Columbia Cancer AgencyOTHER	1	Feb 21, 2023	clinicaltrials
NCT02174679	68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)	no longer available	—	—	Jonsson Comprehensive Cancer CenterOTHER	1	Jul 27, 2020	clinicaltrials